World Health Organization. The global epidemiology of infectious diseases. Murray CJL, Lopez AD, Mathers CD, editors. 4th Volume. Geneva: World Health Organization; 2004. [
Link]
Mun SH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, et al. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine. 2013;20(8-9):714-8. [
Link] [
DOI:10.1016/j.phymed.2013.02.006]
Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine. 2003;82(5):322-32.
https://doi.org/10.1097/01.md.0000091184.93122.09 [
Link] [
DOI:10.1097/01.md.0000091185.93122.40]
Liu J, Xu L, Liu Ch, Zhang D, Wang S, Deng Z, et al. Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohydr Polym. 2012;90(1):16-22. [
Link] [
DOI:10.1016/j.carbpol.2012.04.036]
Basniwal RK, Buttar HS, Jain VK, Jain N. Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. J Agric Food Chem. 2011;59(5):2056-61. [
Link] [
DOI:10.1021/jf104402t]
Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6(1):10. [
Link] [
DOI:10.1186/1472-6882-6-10]
Shome S, Talukdar AD, Choudhury MD, Bhattacharya MK, Upadhyaya H. Curcumin as potential therapeutic natural product: A nanobiotechnological perspective. J Pharm Pharmacol. 2016;68(12):1481-500. [
Link] [
DOI:10.1111/jphp.12611]
Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: Development of an antimicrobial gel formulation for topical use. Mol Pharm. 2009;6(5):1388-401. [
Link] [
DOI:10.1021/mp900056g]
Blecher K, Nasir A, Friedman A. The growing role of nanotechnology in combating infectious disease. Virulence. 2011;2(5):395-401. [
Link] [
DOI:10.4161/viru.2.5.17035]
Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials. 2000;21(23):2475-90. [
Link] [
DOI:10.1016/S0142-9612(00)00115-0]
Leardi R. Experimental design in chemistry: A tutorial. Anal Chim Acta. 2009;652(1-2):161-72. [
Link] [
DOI:10.1016/j.aca.2009.06.015]
Rajasimman M, Sangeetha R, Karthik P. Statistical optimization of process parameters for the extraction of chromium (VI) from pharmaceutical wastewater by emulsion liquid membrane. Chem Eng J. 2009;150(2-3):275-9. [
Link] [
DOI:10.1016/j.cej.2008.12.026]
Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85-94. [
Link] [
DOI:10.1016/j.tips.2008.11.002]
Akram M, Shahab-Uddin AA, Usmanghani K, Hannan A, Mohiuddin E, Asif M. Curcuma longa and curcumin: A review article. Rom J Biol Plant Biol. 2010;55(2):65-70. [
Link]
Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. In: Aggarwal BB, Surh YJ, Shishodia Sh, editors. The molecular targets and therapeutic uses of curcumin in health and disease. Boston: Springer; 2007. pp. 453-470. [
Link] [
DOI:10.1007/978-0-387-46401-5_20]
Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices. 2004;1(1):115-25. [
Link] [
DOI:10.1586/17434440.1.1.115]
Adahoun MA, Al-Akhras MAH, Jaafar MS, Bououdina M. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45(1):98-107. [
Link] [
DOI:10.3109/21691401.2015.1129628]
Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. Coping with antibiotic resistance: Combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther. 2011;9(11):1035-52. [
Link] [
DOI:10.1586/eri.11.121]
